PLUR (Pluri) חוב לטווח קצר להון

Pluri Inc. (PLUR) specializes in the industrial creation of cellular structures using 3D technologies for medicine and nutrition. The price history on GURU.Markets shows the indicator 0.00. The business relies on ESG principles when operating bioreactors and adheres to strict bioethics. To reduce costs, Pluri Inc. (PLUR) delegates the final stages of drug testing to external partners while maintaining its leadership in cultivation.

A comparative asset analysis requires a liquidity assessment via the ratio of liabilities under one year to equity, where the value of 0.00 determines the level of financial pressure on the business. For Pluri Inc. (PLUR), this proportion of short-term debt to equity is critical, as the costs of scaling cell lines and clinical therapy trials directly impact default risk or resource efficiency.